retatrutide clinical trial saudi arabia Lilly's 'triple G' agonist triumphs in Phase III trial, but AEs unnerve analysts Retatrutide Phase 3: 60% Achieved

Weeks 34: 2 mg once weekly (Increase only if early GI symptoms are mild and stable) Weeks 58 : 4 mg once weekly Weeks 912: 8 mg once weekly Week 13+: 12 mg once weekly (Only escalate to higher doses if indicated and previous doses were well tolerated) Balanced schedule: Standard trial-inspired ramp This schedule follows a typical balanced titration pace similar to what many clinical trials use

Providers evaluate each patients health history, goals, and lifestyle before recommending treatment options

Results from the TRIUMPH-4 trial, published in December 2025, showed participants with obesity and knee osteoarthritis taking retatrutide 12mg lost an average of 28.7% of their body weight at 68 weeks

And depending on your situation, certain supplements might be helpful toojust run it by a healthcare professional, like a Midi clinician, first